首页 | 本学科首页   官方微博 | 高级检索  
     

泰素治疗八例晚期复发的卵巢癌
引用本文:洪婉君,刘丽影. 泰素治疗八例晚期复发的卵巢癌[J]. 肿瘤学杂志, 1997, 0(1)
作者姓名:洪婉君  刘丽影
作者单位:中国医学科学院中国协和医科大学肿瘤医院!北京,100021
摘    要:目的:验证泰素对晚期、复发的卵巢上皮癌的疗效。方法:回顾分析1994年7月至1995年3月国内最早试用美国百时美施贵宝公司提供的商用泰素治疗8例卵巢癌的结果。结果:8例可评价病人中,3例达到部分反应(PR),总反应率37.5%(3/8),主要副作用是脱发、腹痛、腹泻和感觉异常。结论:证明泰素对晚期、复发的卵巢上皮癌治疗的有效性,特别是有效者明显延长了生存期。

关 键 词:卵巢肿瘤  泰素

Paclitaxel(Taxol) Therapy in Advanced or Recurrent Ovarian Carcinoma:A Report of 8 Cases
Hong Wanjun, Liu Liying. Paclitaxel(Taxol) Therapy in Advanced or Recurrent Ovarian Carcinoma:A Report of 8 Cases[J]. Journal of Chinese Oncology, 1997, 0(1)
Authors:Hong Wanjun   Liu Liying
Abstract:Purpose: To verify the efficacy of taxol therapy in advanced and recurrent ovarian epithelial carcinoma. Method: A retro-spective analysis was undertaken for 8 patients with advanced or recurrent ovarian epithelial carcinoma who were treated with Taxol(Bristol-Myers squibb company)from July 1994 to March 1995. Results: Overall response rate was 37. 5 % (3/8). The main side ef-fects were alopecia, abdominal pain, diarrhea and paresthesia. Conclusion: The report confirmed the efficacy of taxol therapy in advancedand recurrent ovarian epithelial carcinoma, especially the taxol therapy could significantly prolong survival perlod for responder.
Keywords:Ovarian neoplasms Taxol
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号